<DOC>
	<DOCNO>NCT01652001</DOCNO>
	<brief_summary>The aim study evaluate clinical efficacy topical sialogogue spray contain 1 % malic acid patient affect xerostomia cause drug . This research take form double-blind , randomize clinical trial Faculty Dentistry University Granada ( Spain ) . Participants antidepressant-induced antihypertensive-induce xerostomia divide two group : first 'intervention group ' topical sialogogue spray ( 1 % malic acid ) apply , second 'control group ' , placebo spray apply ; group spray apply demand two week . The Dry Mouth Questionnaire ( DMQ ) use evaluate xerostomia level product/placebo application . Unstimulated stimulate salivary flow rate , application , measure .</brief_summary>
	<brief_title>Drug-induced Xerostomia . Evaluation Malic Acid 1 % , Salivary Mucins Buffering Capacity</brief_title>
	<detailed_description>- Patients study Design The study approve University Granada Research Ethics Committee ( Spain ) . All measurement intervention undertake understand write consent participant accord Helsinki II Agreement.The study design double-blind randomized clinical trial follow guideline establish The Consort Statement ( http : //www.consort-statement.org/consort-statement/ ) . All study participant recruit Faculty Dentistry University Granada ( Spain ) Drug Interactions Dentistry clinical practice , September December 2011 . Recruitment supervise research assistant . All participant full medical history saliva sample collect Faculty Dentistry University Granada ( Spain ) Pharmacological Investigation Dentistry Research Group laboratory ( CTS-654 ) . Sample size determination base standard deviation main variable : Dry Mouth Questionnaire ( DMQ ) test determine minimum sample size necessary reliably confirm hypothesis topical 1 % malic acid sialogogue spray , combine xylitol fluoride , effective treatment xerostomia induce antidepressant drug two-week period . DMQ saliva collection measure day investigator . - Clinical Intervention Once participant sign informed consent form anamnesis carry , follow question ask every patient : `` How often feel dry mouth ? '' Available answer : `` never '' , `` sometimes '' , `` usually '' `` always . '' Those answer `` usually '' `` always '' consider suffer xerostomia . Our clinical intervention among intervention group subject delivery patient topical sialogogue , contain 1 % malic acid , xylitol 10 % fluoride0.05 % ( Xeros Dentaid SprayÂ© , Dentaid , Barcelona , Spain ) two week , whereas control group give placebo presentation composition ( except 1 % malic acid ) . Randomization perform use website http : //www.randomization.com , obtain randomization plan , assign participant either intervention group control group . This randomization plan deliver person unrelated study order prevent participant researcher identify product.Both spray transfer foreign personnel two identical opaque flask ( without brand name ) label A B containing respectively , either 1 % malic acid placebo.A code randomization keep opaque envelope safe environment open end study . Data analyze third party blind allocation result . 1 % malic acid/placebo spray apply demand , maximum eight dos per day . No participant leave trial . - Dry Mouth Questionnaire ( DMQ ) The DMQ , develop Vissink et al. , Gravenmade et al. , van der Reijden et al . Regelink et al . use order obtain subjective information severity xerostomia treatment malic acid/placebo . Every participant answer initial questionnaire ( DMQ 1 ) symptom related oral dryness , receive spray ( 1 % malic acid placebo ) . After two week application , patient answer DMQ 1 well additional questionnaire ( DMQ 2 ) efficacy spray . Increased DMQ score indicate improvement xerostomia . DMQ 1 use assess initial severity oral dryness particular impact oral function : problem chew , swallow , speak general impact daily life . DMQ 1 use 0-to-4 rating scale 0 = `` dry '' 4 = `` dry . '' After two week treatment , DMQ 1 repeat . DMQ 2 design assess impact spray symptom xerostomia , also base 0-to-4 rating scale 0 = frequent restriction oral function 4= restriction oral function/no feel oral dryness . The effect frequency duration spray application oral cavity also register . - Sialometries As secondary measurement , unstimulated stimulate salivary flow rate assess patient . The unstimulated salivary flow rate obtain spit method every 30 second 15 minute . Saliva collect 20 mL plastic container , pre-weighted ( 0.001 g ) use precision scale . Measurements express mL/min . Stimulated whole saliva obtain chew 1 g piece paraffin wax six minute . Saliva collect first minute discard , collect container every 30 second . Both DMQ sialometries always assess time day ( 09:00 11:00 a.m. ) avoid circadian variation . Before evaluation , participant ask eat , drink , smoke brush teeth one hour prior appointment clinic.Time pass last use sialogogue salivary flow measurement 6 hour .</detailed_description>
	<mesh_term>Xerostomia</mesh_term>
	<criteria>Xerostomia Drug consumption Antidepressant antihypertensive agent Systemic disease Head neck radiotherapy Intake drug high xerostomizing capacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Xerostomia</keyword>
	<keyword>Antidepressant agent</keyword>
	<keyword>Antihypertensive agent</keyword>
</DOC>